The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
HGCSG1902: Multicenter, prospective, observational study for patients with dysgeusia caused by chemotherapy for gastrointestinal cancer.
 
Ken Ito
No Relationships to Disclose
 
Satoshi Yuki
Honoraria - Bayer Yakuhin; Bristol-Myers Squibb Japan; Chugai Pharma; Lilly Japan; Medical & Biological Laboratories; Merck; MSD K.K; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Hiroshi Nakatsumi
Honoraria - Bayer Yakuhin; Chugai Pharma; Lilly Japan; Ono Pharmaceutical; Sanofi; Taiho Pharmaceutical; Takeda
 
Takayuki Ando
No Relationships to Disclose
 
Kentaro Sawada
No Relationships to Disclose
 
Masataka Yagisawa
No Relationships to Disclose
 
Atsushi Ishiguro
No Relationships to Disclose
 
Masayoshi Dazai
No Relationships to Disclose
 
Ichiro Iwanaga
No Relationships to Disclose
 
Kazuteru Hatanaka
No Relationships to Disclose
 
Atsushi Sato
No Relationships to Disclose
 
Ryusuke Matsumoto
No Relationships to Disclose
 
Yoshiaki Shindo
No Relationships to Disclose
 
Miki Tateyama
No Relationships to Disclose
 
Tetsuhito Muranaka
No Relationships to Disclose
 
Masaki Katagiri
No Relationships to Disclose
 
Isao Yokota
Speakers' Bureau - AstraZeneca; Chugai Pharma; JT Pharmaceuticals; Nippon Shinyaku
Research Funding - Nihon Medi-Physics
 
Yuh Sakata
Stock and Other Ownership Interests - Delta-Fly Pharma (I)
Honoraria - Chugai Pharma; Daiichi Sankyo; Taiho Pharmaceutical; Yakult Honsha
 
Naoya Sakamoto
No Relationships to Disclose
 
Yoshito Komatsu
Honoraria - Asahi Kasei; Bayer Yakuhin; Bristol-Myers Squibb Co.; Chugai Pharma; Daiichi Sankyo; Lilly Japan; Medical Review Co., Ltd.; Merck; Mitsubishi Tanabe Pharma; Moroo Co.; Nipro Corporation; Ono Pharmaceutical; Otsuka; Sanofi/Aventis; Taiho Pharmaceutical; Takeda; Yakult Honsha
Research Funding - A2 Healthcare; Astellas Pharma; Bayer Yakuhin; BeiGene (Inst); DAIICHI SANKYO CO., LTD.; Eisai; Incyte; IQvia; Lilly (Inst); Mediscience Planning; MSD K.K.; NanoCarrier; Nipro Corporation (Inst); Ono Pharmaceutical; Parexel International Corporation.; Sanofi/Aventis; Shionogi; Sumitomo Dainippon Pharma Co., Ltd.; Sysmex; Taiho Pharmaceutical; Yakult Honsha